- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01801865
Clinical Use of a New Neonatal MRI System
October 2, 2020 updated by: Children's Hospital Medical Center, Cincinnati
The purpose of the present study is to make medically indicated state of the art/high end magnetic resonance imaging (MRI) exams available to all infants in the Cincinnati Children's Hospital Medical Center (CCHMC) Neonatal Intensive Care Unit (NICU).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The current practice of transferring infants from the Neonatal Intensive Care Unit (NICU) to radiology departments and imaging in adult-sized magnetic resonance imaging (MRI) scanners is associated with significant safety and image quality issues.
For these reasons, the smallest and/or sickest neonates are typically precluded from receiving an MRI exam.
The overreaching goal of our research effort is to bring high-performance MRI into the NICU so that all neonates can benefit from the same quality of diagnostic imaging as adults.
To accomplish this, we have converted a commercial small-bore 1.5 Tesla (T) MRI scanner designed for orthopedic use into a neonatal MRI system optimized for whole body imaging of neonates.
To expand the imaging capabilities of the NICU MRI system, the measurement control electronics and operating system software of the FDA cleared imaging OPTIMA platform have been augmented with state of the art HDX electronics and software currently used on a conventional commercially available adult sized whole body MRI scanner.
The clinical safety of the integrated HDX/OPTIMA NICU MRI system and its ability to produce diagnostic image quality has been shown in 15 pilot patients (CCHMC Protocol 2011-2045).
The present protocol builds and expands upon the previous to use the integrated NICU MRI system to perform MRI exams in the neonatal population.
Study Type
Interventional
Enrollment (Actual)
657
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Cincinnati, Ohio, United States, 45229
- NICU, Cincinnati Children's Hospital Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Any infant admitted to the NICU at CCHMC
- Have a medical condition for which an MRI exam is indicated, as determined by the attending neonatologist
- Able to maintain body temperature for at least 90 minutes without the aid of an incubator or radiant warmer int he opinion of the attending neonatologist
- Parental/LAR permission obtained
Exclusion Criteria:
- Infants too large to fit in the customized NICU MRI system comfortably (expected to be infants heavier than 6 kg)
- Standard MRI exclusion criteria as set forth by the CCHMC Division of Radiology
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: MRI for Neonates
All participants will receive an MRI in the NICU scanner in the GE OPTIMA 1.5T MRI at CCHMC.
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants With Adverse Events as Observed During and After Scanning.
Time Frame: Day 1
|
Any observed physical changes either related or not related to the MRI was recorded during and after scanning.
|
Day 1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Each Infant's Baseline Measurement for Weight Will be Recorded to Ensure the Infant is Less Than 6 kg.
Time Frame: Day 1
|
These measures will be used in order to facilitate future design of coils and transport tables for the customized MRI system.
|
Day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Beth M Kline-Fath, MD, Children's Hospital Medical Center, Cincinnati
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2012
Primary Completion (Actual)
December 1, 2017
Study Completion (Actual)
March 1, 2018
Study Registration Dates
First Submitted
July 25, 2012
First Submitted That Met QC Criteria
February 27, 2013
First Posted (Estimate)
March 1, 2013
Study Record Updates
Last Update Posted (Actual)
October 27, 2020
Last Update Submitted That Met QC Criteria
October 2, 2020
Last Verified
October 1, 2020
More Information
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Magnetic Resonance Imaging
-
BayerCompletedMagnetic Resonance Imaging | Magnetic Resonance AngiographyPoland, China, France, Germany, Hungary, Korea, Republic of, South Africa, Spain, Thailand, Taiwan, Czech Republic, Hong Kong, Italy, Kazakhstan, Russian Federation, Bosnia and Herzegovina, Greece, Canada, Vietnam, Kyrgyzstan
-
Centre Hospitalier Régional Metz-ThionvilleUniversity of LorraineRecruitingMagnetic Resonance ImagingFrance
-
Centre Hospitalier Universitaire, AmiensCompletedMagnetic Resonance ImagingFrance
-
Jessa HospitalCompletedMagnetic Resonance ImagingBelgium
-
BayerCompletedMagnetic Resonance ImagingUnited States, Korea, Republic of, France, Germany, Italy, Switzerland, United Kingdom
-
Boston Scientific CorporationCompletedMagnetic Resonance ImagingSpain, Hong Kong, Germany, Israel, United Kingdom, Italy, United States, Malaysia, Belgium
-
MegaPro Biomedical Co. Ltd.CompletedMagnetic Resonance ImagingTaiwan
-
BayerCompletedMagnetic Resonance ImagingJapan
-
BayerCompletedMagnetic Resonance ImagingPhilippines
-
BayerCompletedMagnetic Resonance Imaging | Myocardial Perfusion ImagingSwitzerland, Germany, Austria, Poland
Clinical Trials on GE OPTIMA MR430s with HDX/GE Electronics
-
Children's Hospital Medical Center, CincinnatiCompleted
-
Children's Hospital Medical Center, CincinnatiCompletedSafety of a Customized NICU MRI SystemUnited States
-
GE HealthcareCompleted
-
Tel-Aviv Sourasky Medical CenterUnknown
-
Ankara City Hospital BilkentCompletedRespiratory Failure | Bronchopulmonary Dysplasia | Mechanical Ventilation Complication | Newborn MorbidityTurkey
-
GE HealthcareUnknown
-
Brigham and Women's HospitalGeneral ElectricCompletedPleural Effusion | SplenomegalyUnited States
-
GE HealthcareTerminatedBlood Pressure (Low, Normal, High)United States
-
Massachusetts General HospitalGE HealthcareCompletedFatty Liver | Nonalcoholic Steatohepatitis | Nonalcoholic Fatty LiverUnited States